Flu A, or influenza A, is the most common and most dangerous type of influenza virus. It’s the only type capable of causing pandemics, and it’s responsible for the majority of flu hospitalizations and deaths each season. Unlike influenza B, which circulates only among humans, influenza A infects birds, pigs, horses, and other animals, giving it a much larger reservoir to mutate and produce new strains.
How Influenza A Differs From Other Flu Types
There are four types of influenza virus: A, B, C, and D. Only A and B cause significant seasonal illness in humans. Influenza C produces mild symptoms, and influenza D primarily affects cattle.
What sets influenza A apart is its surface. The virus is covered in two types of proteins: hemagglutinin (H) and neuraminidase (N). There are 18 known hemagglutinin subtypes and 11 neuraminidase subtypes, creating a huge number of possible combinations. These combinations define the virus’s subtype, which is why you see names like H1N1 and H3N2. The H protein helps the virus latch onto and enter your cells. The N protein helps newly made virus particles break free from the cell to spread further. Influenza B doesn’t have this subtype system, which limits how much it can change from year to year.
The two influenza A subtypes that currently circulate in humans are H1N1 and H3N2. H3N2 tends to cause more severe seasons, particularly among older adults.
Symptoms and How Long They Last
Flu A symptoms come on suddenly, typically one to two days after exposure. The most common signs include fever, chills, muscle aches, headache, fatigue, cough, sore throat, and a runny or stuffy nose. Some people also experience vomiting and diarrhea, though this is more common in children than adults.
Most healthy people recover within one to two weeks, though fatigue and cough can linger. The illness tends to peak around days two through four, with fever usually breaking within five days.
How It Spreads
Influenza A spreads through three routes: respiratory droplets (from coughing, sneezing, or talking), smaller airborne particles that can float in the air, and contact with contaminated surfaces. On hard, non-porous surfaces like stainless steel and plastic, the virus can survive more than 24 to 48 hours at typical indoor humidity levels. On porous materials like paper, fabric, and tissues, it drops to undetectable levels within 8 to 12 hours. If you touch a stainless steel surface with live virus on it, the virus can transfer to your hands for up to 24 hours. On a paper tissue, that window shrinks to just 15 minutes.
You become contagious about one day before symptoms appear and remain contagious for five to seven days after getting sick. The first three days of illness are the most contagious period. Young children and people with weakened immune systems may shed the virus for even longer.
Why Flu A Causes Pandemics
Influenza A is the only flu type with pandemic potential because it circulates in animals, especially birds and pigs. When an animal strain mutates in a way that lets it infect humans efficiently, most people have no pre-existing immunity, and the virus can spread rapidly worldwide.
Several animal-origin strains have caused serious concern. H5N1 (bird flu) has been circulating in poultry for decades and jumped to dairy cattle in the United States in 2024, with some dairy farm workers becoming infected through direct contact with sick cows. H7N9 emerged in China in 2013, spread through poultry populations, and caused over 1,500 confirmed human infections with many deaths between 2013 and 2019. Human cases of these avian strains range from mild, flu-like illness or eye inflammation to severe respiratory disease and death, with fatality rates far higher than seasonal flu. The key risk factor for infection is direct or indirect contact with infected animals, not typical person-to-person spread.
Who Faces the Highest Risk
Flu A can be dangerous for anyone, but certain groups face a much higher chance of complications like pneumonia, organ failure, or worsening of chronic conditions. Those at increased risk include:
- Adults 65 and older
- Children younger than 2 (infants under 6 months have the highest hospitalization and death rates)
- Pregnant women, including up to two weeks postpartum
- People with chronic conditions such as asthma, COPD, heart disease, diabetes, kidney disease, liver disease, sickle cell disease, or a BMI of 40 or higher
- People with weakened immune systems from HIV, cancer, organ transplant, or immunosuppressive medications
- People with neurologic or neurodevelopmental conditions that affect muscle function, swallowing, or the ability to clear their airways
- Residents of nursing homes and long-term care facilities
Racial and ethnic disparities also play a role. Non-Hispanic Black, Hispanic or Latino, and American Indian or Alaska Native populations face higher rates of flu hospitalization.
Testing for Flu A
The most common test is a rapid influenza diagnostic test (RIDT), which gives results in about 15 minutes using a nasal swab. These tests can distinguish between influenza A and B. For flu A detection, rapid tests have a sensitivity ranging from roughly 80% to 92%, meaning they catch most infections but can miss some, particularly when viral levels are low. Their specificity is nearly 99%, so a positive result is very reliable.
When a more definitive answer is needed, especially in hospitalized patients or during outbreaks, molecular PCR testing is used. PCR is considered the gold standard and is significantly more sensitive than rapid tests, though results can take several hours.
Treatment Options
Antiviral medications work best when started within the first 48 hours of symptoms. The most widely prescribed antiviral is a twice-daily oral medication taken for five days. A newer option requires only a single dose on one day. Both reduce symptom duration by roughly one to two days and can lower the risk of complications in high-risk individuals. Antivirals are most strongly recommended for people at high risk, those sick enough to be hospitalized, and those with severe or worsening symptoms.
For most otherwise healthy people, flu A resolves on its own with rest, fluids, and over-the-counter fever and pain relievers.
How Well the Vaccine Works
The seasonal flu vaccine is reformulated every year to match circulating strains, and its effectiveness varies depending on how well the vaccine matches what’s actually spreading. Preliminary CDC data for the 2024-2025 season illustrates this variability clearly.
Against H1N1, the vaccine reduced outpatient flu visits by about 53% to 72% in children and adolescents, and by roughly 42% in adults. Against H3N2, effectiveness was lower: around 16% to 42% in children (depending on the study network) and 25% to 51% in adults. Protection against hospitalization generally tracked in a similar range.
Even in years when effectiveness is moderate, vaccination reduces the severity of illness if you do get infected and lowers the chance of hospitalization and death, particularly for high-risk groups. Annual vaccination remains the single most effective preventive measure against flu A.